These insights could drive the development of new drugs to treat transthyretin amyloidosis, a progressive and fatal disease.

The tiny protein known as transthyretin can cause big problems in the body when it misfolds after secretion. While healthy ...

“We found that harvesting a high proportion of the adult males in the herd – around 40% every year for 20 years, is expected ...

Inc. (Nasdaq: PMN), a clinical-stage biotechnology company focused on the generation and development of antibody therapeutics ...

Insights into the structures could lead to improved treatment strategies for transthyretin amyloidosis, a progressive, fatal disease in men.

The tiny protein known as transthyretin can cause big problems in the body when it misfolds after secretion. While healthy transthyretin moves ...

Parkinson’s disease is one of a number of neurodegenerative conditions, including Alzheimer’s and prion diseases, that are characterized by the accumulation of protein aggregates in the brain, Miller ...

ProMIS Neurosciences Inc., a clinical-stage biopharmaceutical company, made significant disclosures in its recent 8-K filing with the Securities and Exchange Commission. In its filing dated January 27 ...

Cerca Biotech has announced the start of Shuwen Biotech's ‘PreShield Study’ in China to assess ‘CercaTest RED’, a urine-based ...